Preclinical Evaluation of eFT226, a Novel, Potent and Selective eIF4A Inhibitor with Anti-Tumor Activity in B-Cell Malignancies
暂无分享，去创建一个
P. A. Thompson | K. Webster | N. Young | G. Chiang | P. Sprengeler | C. Wegerski | J. Ernst | B. Eam | Theo D. Michels | Christian Nilewski | S. Sperry | A. Xiang | Joan W Chen | Jeff Clarine | S. Fish | M. Barrera | H. Howard | Ana Parra | J. Staunton | Andres Nevarez | G. Packard | I. N. Hung | Jolene Molter | G. Parker | R. S. Heinz | Tran Chinh Viet